10月24日，直觉外科公司盘中上涨3.01%，报457.24美元/股，成交额6.55亿美元。
消息面上，Rothschild & Co Redburn将直觉外科目标价由540美元上调至560美元，带动市场情绪继续修复。
此前公司第三季度调整后每股收益3.00美元、营收30.49亿美元，均高于预期；尽管管理层收紧了机器人手术量增长展望，且机构提示美国定价调整及中国收费编码下调或对后续手术量动能构成扰动，但最新目标价上调显示部分机构仍认可其中长期竞争力与基本面韧性。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.